Cagrilintide
卡瑞林肽
Report date: 2026/05/25 20:02:40
NME
Base Information
Drug NameCagrilintide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[45]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk A/SNovo Nordisk (China)Pharmaceuticals Co LtdNovo Nordisk Pharmaceuticals
Inactive CompaniesN/A
Active Indications +[8]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A